Bailard Inc. bought a new stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 3,023 shares of the company's stock, valued at approximately $283,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Westend Capital Management LLC grew its position in shares of Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after buying an additional 140 shares in the last quarter. Cornerstone Planning Group LLC lifted its position in Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after buying an additional 287 shares during the period. Vermillion Wealth Management Inc. purchased a new position in shares of Colgate-Palmolive in the 4th quarter worth about $31,000. Bernard Wealth Management Corp. acquired a new stake in Colgate-Palmolive during the 4th quarter valued at approximately $33,000. Finally, Accredited Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $34,000. Hedge funds and other institutional investors own 80.41% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on CL shares. Citigroup boosted their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Wells Fargo & Company raised their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research note on Wednesday, April 2nd. Piper Sandler lowered their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research report on Monday, March 31st. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. Finally, Barclays increased their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 15th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of "Hold" and an average price target of $100.64.
View Our Latest Analysis on Colgate-Palmolive
Colgate-Palmolive Stock Performance
NYSE:CL traded down $0.25 during trading hours on Thursday, reaching $88.54. The company had a trading volume of 624,289 shares, compared to its average volume of 5,238,802. The firm's 50 day moving average price is $90.33 and its 200-day moving average price is $90.33. The firm has a market cap of $71.76 billion, a price-to-earnings ratio of 25.04, a PEG ratio of 4.68 and a beta of 0.37. Colgate-Palmolive Company has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a current ratio of 0.85, a quick ratio of 0.54 and a debt-to-equity ratio of 8.96.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.86 by $0.05. The company had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The firm's revenue was down 3.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.86 EPS. On average, analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.76%.
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.